![](/img/cover-not-exists.png)
Post-treatment with an ultra-low dose of NADPH oxidase inhibitor diphenyleneiodonium attenuates disease progression in multiple Parkinson’s disease models
Wang, Qingshan, Qian, Li, Chen, Shih-Heng, Chu, Chun-Hsien, Wilson, Belinda, Oyarzabal, Esteban, Ali, Syed, Robinson, Bonnie, Rao, Deepa, Hong, Jau-ShyongVolume:
138
Language:
english
Journal:
Brain
DOI:
10.1093/brain/awv034
Date:
May, 2015
File:
PDF, 2.03 MB
english, 2015